In Investigations, the most common AEs are Blood glucose increased and Prostatic specific antigen increased, which align with the drug’s prescribing information and previous HERO trial results.2 These events are attributed to metabolic abnormalities caused by testosterone suppression and changes in body composition, including Metabolism and nutrition disorders such as Weight loss poor and Glucose tolerance impaired. This evidence concerns the gene KLK3 and Impaired glucose tolerance.